Registry collecting data on cardiac PET and CardioFlux Magnetocardiography for coronary ischemia detection
Official title: A Registry of Cardiac PET and CardioFlux Magnetocardiography in Patients With Suspected Coronary Ischemia.
Run by Genetesis Inc. · NCT05868902 · Data updated 2026-11-12
This study is collecting information from patients who might have coronary ischemia to see if a new heart imaging method can help find this condition better than the standard tests.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 40 Years and up |
| Sex | All |
| Enrollment | 300 (estimated) |
| Sponsor | Genetesis Inc. Industry-sponsored |
| Locations | 2 sites (Cleveland, Ohio and 1 other locations) |
| Status | Recruiting |
| Started | August 28, 2023 |
| Main results expected | June 1, 2025 |
| Study ends | December 31, 2025 |
| Registry record updated | February 20, 2025 |
| Trial ID | NCT05868902 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals aged 40 and older with a clinical suspicion of myocardial ischemia who have recently completed a cardiac PET.
✕Probably not a fit
Patients with implanted ferromagnetic devices or those unable to lie supine for the required duration may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational registry aims to gather diagnostic data from patients suspected of having coronary ischemia by utilizing standard cardiac PET imaging. It will also explore the potential role of CardioFlux Magnetocardiography in enhancing the detection of this condition. The study involves multiple centers and focuses on patients who have recently undergone cardiac PET. By analyzing the collected data, researchers hope to improve understanding and diagnostic capabilities for coronary ischemia.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic techniques for coronary ischemia, potentially enhancing patient outcomes.
How similar studies have gone: While the use of cardiac PET is well-established, the application of CardioFlux Magnetocardiography in this context is relatively novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Willing to provide informed consent * Male or female, aged 40 and up (inclusive) at the time of enrollment * Clinical suspicion of myocardial ischemia that clinician desired cardiac PET * Completed cardiac PET within 2 weeks prior to study enrollment Exclusion Criteria: * Patients unable to fit into CardioFlux device. * Patients unable to lie supine for 5 minutes. * Patients with implanted ferromagnetic objects above the costal margin of the rib cage (implanted pacemakers, cardioverter/defibrillators, infusion pumps, and/or neuro stimulators). NOTE: Sternotomy wires stents are acceptable * Ongoing atrial fibrillation or atrial flutter * Life expectancy \<1 yrs. due to non-cardiovascular comorbidity
Where it's running
-
Cleveland Clinic
Cleveland, Ohio, United States Recruiting -
Kettering Health
Kettering, Ohio, United States Recruiting
Study contacts
- Study coordinator: Zoe E Swann, PhD
- Email: zoe.swann@genetesis.com
- Phone: 4802868695
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Evaluating the usefulness of cardiovascular CT imaging for predicting outcomes
This study is trying to see if heart scans can help predict serious health issues and outcomes for patients with heart problems over a 10-year period.
-
Stratified medicine approach for managing angina without obstructive coronary artery disease
This study is testing if a personalized treatment plan based on a special heart test can help people with angina who don’t have blocked arteries feel better and improve their health.
-
Early LDL-C lowering with evolocumab after ACS to see if it slows plaque progression
This trial tests whether starting evolocumab soon after a heart attack or unstable angina, in addition to standard therapy, reduces non-culprit plaque growth over a year.
-
Apixaban with or without Clopidogrel in stroke patients with NVAF and intracranial/extracranial atherosclerosis
This study tests whether adding clopidogrel to apixaban is safe and helpful for people with acute ischemic stroke due to non-valvular atrial fibrillation and atherosclerosis.
-
Improving heart assessment in fetuses and newborns
This study is testing new ways to check the heart health of unborn babies and newborns to help prevent serious problems during delivery.
-
Using platelet expression and blood flow analysis to predict recurrent stroke risk
This study is trying to see if certain blood cell markers and blood flow patterns can help predict the risk of having another stroke in people who have already had a minor stroke or a temporary stroke-like event.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.